Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

"IL-1β Blockade to Prevent Immunothrombosis in Recipients of a Pancreatic Organ (ILIPO)"

NCT07503834 is registered in ClinicalTrials.gov with Nantes University Hospital as lead sponsor.

NCT NCT07503834
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07503834 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
"IL-1β Blockade to Prevent Immunothrombosis in Recipients of a Pancreatic Organ (ILIPO)"
Lead sponsor
Nantes University Hospital
Phase
Phase 1/2
Overall status
Recruiting
Start date
October 7, 2026
Completion date
April 7, 2029
Enrollment
15 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic transplant